Less Ads, More Data, More Tools Register for FREE

Pin to quick picksM P Evans Regulatory News (MPE)

Share Price Information for M P Evans (MPE)

Share Price is delayed by 15 minutes
Get Live Data
1,482.00    -20.00 (-1.33%)
Bid:
1,468.00
Ask:
1,478.00
Spread: 10.00 (0.681%)
Market Cap: £772.28m
MPE Live PriceLast checked at - London Stock Exchange

Intraday M P Evans Share Chart

PDMR transaction & Total Voting Rights

22 Sep 2017 14:32

RNS Number : 6063R
M. P. Evans Group PLC
22 September 2017
 

 

 

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

 

M.P. Evans Group Plc

(the "Company" or "M.P. Evans")

 

PDMR transaction

 

and

 

Total Voting Rights

 

PDMR transaction

 

The Company has been notified of the exercise of share options today under the executive share-option scheme by Mr TRJ Price, a director of the Company. Mr TRJ Price exercised his share options over 75,000 ordinary shares of 10p each in the capital of the Company ("Ordinary Shares") granted at 385p per Ordinary Share and due to expire on 16 November 2017. Accordingly, the Company issued Mr TRJ Price 75,000 Ordinary Shares.

 

Simultaneously, Mr TRJ Price sold 57,000 Ordinary Shares at 742.5p per Ordinary Share in order to fund the exercise cost of the share options and the associated tax liabilities. In addition, Mr TRJ Price transferred the remaining 18,000 Ordinary Shares to Mrs JA Price, Mr TRJ Price's wife.

 

Total Voting Rights

 

Following the above transactions the Company has 55,137,992 Ordinary Shares in issue. All of the Ordinary Shares have equal voting rights and there are no Ordinary Shares held in Treasury.

 

The above figure of 55,137,992 represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

 

 1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Tristan Price

2

Reason for the notification

 

a)

Position/status

 

Chief Executive Officer

b)

Initial notification/Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

M.P.Evans Group PLC

b)

LEI

 2138003IBXJUCR4SZG26

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Ordinary shares of 10 pence per share in M.P.Evans Group PLC ("Ordinary Shares").

 

Identification code: ISIN GB007538100

 

b)

Nature of the transaction

Exercise of options over Ordinary Shares

Sale of Ordinary Shares

Transfer of Ordinary Shares

 

c)

Price(s) and volume(s)

 

 

Exercise of share options over Ordinary Shares:

Price(s) 385p (exercise price)

Volume(s) 75,000

 

Sale of Ordinary Shares:

Price(s) 742.5p

Volume(s) 57,000

 

Transfer of Ordinary Shares:

Price(s) Nil

Volume(s) 18,000

 

d)

Aggregated information

 

N/A

 

e)

Date of transaction

22 September 2017

 

f)

Place of transaction

London Stock Exchange (XLON); AIM

 

Enquiries:

M.P. Evans Group PLC Telephone: +44 (0)1892 516333

Peter Hadsley-Chaplin, Chairman

Tristan Price, Chief executive

Matthew Coulson, Finance director

 

Peel Hunt LLP Telephone: +44 (0)20 7418 8900

Dan Webster

Adrian Trimmings

George Sellar

 

Hudson Sandler Telephone: +44 (0)20 7796 4133

Charlie Jack

Bertie Berger

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCXLLFLDKFXBBB
Date   Source Headline
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:30 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20267:00 amRNSTransaction in Own Shares
28th May 20267:00 amRNSTransaction in Own Shares
26th May 20262:42 pmRNSShare Buyback Programme
20th May 202611:26 amRNSIndonesian commodity exporting
12th May 20262:52 pmRNSAGM Arrangements
1st Apr 20265:40 pmRNS2025 Annual Report
26th Mar 202610:16 amRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSFinal Results 2025
5th Mar 20267:00 amRNSNotice of Results
23rd Jan 20267:00 amRNSDirector/PDMR Shareholding
22nd Jan 20267:00 amRNS2025 Crop and production
16th Jan 20261:05 pmRNSDirector/PDMR Shareholding
6th Jan 20267:00 amRNSDirector/PDMR Shareholding
18th Dec 20257:00 amRNSDirector/PDMR Shareholding
16th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 202512:58 pmRNSPublication of 2024 ESG report
2nd Dec 20251:14 pmRNSCompany update
1st Dec 20257:00 amRNSAppointment of joint broker
10th Nov 20257:00 amRNSStrong pricing during second half of 2025
28th Oct 20255:33 pmRNSHolding(s) in Company
22nd Sep 20253:26 pmRNSAIM Rule 20
15th Sep 20257:00 amRNSHalf-year Report
27th Aug 20257:00 amRNSNotice of interim results & investor presentation
29th Jul 20257:00 amRNSPublication of TCFD report
24th Jul 20257:00 amRNS2025 H1 crop and production
14th Jul 202510:07 amRNSAcquisition
7th Jul 20254:54 pmRNSDirector/PDMR Shareholding
30th Jun 20254:30 pmRNSTotal Voting Rights
25th Jun 202511:18 amRNSIssue of Equity
18th Jun 20257:00 amRNSShare buyback programme
13th Jun 20251:45 pmRNSResult of AGM
13th Jun 20257:00 amRNSAGM Statement
12th Jun 20254:50 pmRNSAppointment to board roles
5th Jun 20257:00 amRNSAGM update
14th May 20257:00 amRNSDirectorate Change
22nd Apr 20255:33 pmRNSDirector/PDMR Shareholding
16th Apr 202511:00 amRNSAcquisition
31st Mar 20254:02 pmRNSPosting of Annual Report
25th Mar 20257:00 amRNSFinal Results
21st Mar 20257:00 amRNSDirector retirement
5th Mar 20257:00 amRNSNotice of Results and investor presentation
20th Jan 20253:05 pmRNSDirector/PDMR Shareholding
20th Jan 20257:00 amRNSCrop and production
2nd Jan 202511:31 amRNSDirector/PDMR Shareholding
2nd Jan 20257:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.